Skip to main content
RHHBY
OTC Life Sciences

Roche Wins European Approval for Susvimo in Neovascular AMD

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$55.36
Mkt Cap
$346.232B
52W Low
$39.5
52W High
$60.85
52W Position info
40% above low
Off High info
9.0% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

RHHBY sits 40% above its 52-week low of $39.5 on light trading volume (0.4× avg).

Summary

Roche received European approval for Susvimo, its implantable ranibizumab delivery system, for neovascular age-related macular degeneration. This expands the drug's market beyond the U.S., where it was approved in 2021 but faced manufacturing issues. The approval is a positive regulatory milestone for Roche's ophthalmology portfolio, though the commercial impact will depend on pricing and uptake in Europe.

At the time of this announcement, RHHBY was trading at $55.36 on OTC in the Life Sciences sector, with a market capitalization of approximately $346.2B. The 52-week trading range was $39.50 to $60.85. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

RHHBY - Latest Insights

RHHBY
Oct 25, 2026, 11:30 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $61.17
Real-time Price: $59.37 info
Change: -$1.80 (-3%) info
Market Cap: $386.097B info
RHHBY
Oct 23, 2026, 1:30 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $60.19
Real-time Price: $59.37 info
Change: -$0.820 (-1%) info
Market Cap: $386.097B info
RHHBY
Oct 22, 2026, 12:50 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $59.48
Real-time Price: $59.37 info
Change: -$0.110 (-0.18%) info
Market Cap: $386.097B info
RHHBY
Oct 16, 2026, 1:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $56.78
Real-time Price: $59.37 info
Change: +$2.59 (+5%) info
Market Cap: $386.097B info
RHHBY
Oct 10, 2026, 5:40 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $54.09
Real-time Price: $59.37 info
Change: +$5.28 (+10%) info
Market Cap: $386.097B info